Form 8-K - Current report:
SEC Accession No. 0001193125-26-123543
Filing Date
2026-03-25
Accepted
2026-03-25 13:31:52
Documents
13
Period of Report
2026-03-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d123475d8k.htm   iXBRL 8-K 24063
2 EX-99.1 d123475dex991.htm EX-99.1 32749
6 GRAPHIC g123475g0324082552942.jpg GRAPHIC 7029
  Complete submission text file 0001193125-26-123543.txt   186687

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cort-20260325.xsd EX-101.SCH 2848
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20260325_lab.xml EX-101.LAB 17233
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20260325_pre.xml EX-101.PRE 10810
17 EXTRACTED XBRL INSTANCE DOCUMENT d123475d8k_htm.xml XML 3539
Mailing Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065
Business Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 26790917
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)